+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro synergistic activity of some chinolinic compounds combined with beta-lactam antibiotics against gram-positive and gram-negative clinical isolates



In vitro synergistic activity of some chinolinic compounds combined with beta-lactam antibiotics against gram-positive and gram-negative clinical isolates



ChemoTherapy 31(3): 191-199



The antimicrobial activities of nalidixic acid-cephalexin (ratio 1:1) and cinoxacin-cefadroxil (ratio 1:2) combinations have been evaluated against 396 clinical isolates; many of them were nalidixic acid- or cinoxacin-resistant organisms (MIC greater than or equal to 100 micrograms/ml). We have also tested the nalidixic acid-amoxicillin combination (ratio 1:1) against 225 amoxicillin-resistant bacterial strains (MIC greater than or equal to 800 micrograms/ml). Synergy was found for 62-70% of the Enterobacteriaceae and nonfermenter bacilli tested and for 85-92% of the gram-positive bacterial strains. The 225 clinical isolates resistant to amoxicillin (MIC greater than or equal to 800 micrograms/ml) were synergistically inhibited by the nalidixic acid-amoxicillin combination.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040393797

Download citation: RISBibTeXText

PMID: 3996087


Related references

In vitro Synergistic Activity of Some Chinolinic Compounds Combined with -Lactam Antibiotics against Gram-Positive and Gram-Negative Clinical Isolates. Chemotherapy 31(3): 191-199, 1985

Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria. In Vitro Susceptibility Surveillance Group. Diagnostic Microbiology and Infectious Disease 19(2): 111-120, 1994

Ciprofloxacin bay 09867 comparative activity with beta lactam antibiotics and gentamicin against aerobic gram positive and gram negative bacteria. Abstracts of the Annual Meeting of the American Society for Microbiology 84: ABSTRACT A63, 1984

Synergistic interaction of apalcillin with nine beta lactams against gram positive and gram negative clinical isolates. Abstracts of the Annual Meeting of the American Society for Microbiology 86: 365, 1986

Multicenter study of the in vitro activity of cefepime in comparison with five other broad-spectrum antibiotics against clinical isolates of Gram-positive and Gram-negative bacteria from hospitalized patients in Switzerland. Clinical Microbiology and Infection 5(5): 262-269, 1999

Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates. Drugs Under Experimental and Clinical Research 24(3): 139-151, 1998

Comparison of in vitro activity of trovafloxacin against gram-positive and gram-negative organisms with quinolones and beta-lactam antimicrobial agents. Diagnostic Microbiology and Infectious Disease 31(1): 301-311, 1998

Minimal antibiotic concentrations of aminoglycosides and beta-lactam antibiotics for some gram-negative bacilli and gram-positive cocci. Journal of Infectious Diseases 139(5): 599-603, 1979

In vitro activity of biapenem against recent gram-negative and gram-positive clinical isolates. ChemoTherapy 43(6): 393-393, 1997

In vitro activity of biapenem against clinical isolates of gram-positive and gram-negative bacteria. Antimicrobial Agents and ChemoTherapy 37(9): 2009-2016, 1993

In vitro activity of ABT-773, a novel Ketolide, against clinical isolates of gram-positive and gram-negative cocci. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 187, 2001

In vitro activity of Bay y3118 against multiresistant gram-positive and gram-negative clinical isolates. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 34: 52, 1994

In vitro activity of gemifloxacin against Gram-positive and Gram-negative clinical isolates in Argentina. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 265, 1999

Comparative in vitro activity of trovafloxacin against Gram-positive and Gram-negative clinical isolates from Argentina. Drugs 58(Suppl 2): 195-199, 1999

Comparative in vitro activity of gemifloxacin against gram-positive and gram-negative clinical isolates in Argentina. Diagnostic Microbiology & Infectious Disease 40(4): 187-192, 2001